5-Fluorouracil as an enhancer of aminolevulinate-based photodynamic therapy for skin cancer: New use for a venerable agent?

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7886, Issue , 2011, Pages

  Maytin, Edward V ^a   Anand, Sanjay ^a   Wilson, Clara ^a   Iyer, Karthik ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

5 fluorouracil; differentiation; medicine; patients; Photodynamic therapy; protoporphyrin IX; skin cancer

Indexed keywords

5-FLUOROURACIL; DIFFERENTIATION; PATIENTS; PROTOPORPHYRIN IX; SKIN CANCER;

CELL DEATH; DERMATOLOGY; DISEASES; NUCLEIC ACIDS; PLASMONS; RNA; TUMORS;

PHOTODYNAMIC THERAPY;

EID: 79954539481     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.874188     Document Type: Conference Paper

References (34)

1. Hasan T., Ortel, B., Solban, N., Pogue, B.W. Photodynamic therapy of cancer. In: Bast R KD, Hait W et al., ed. Cancer Medicine. 6th ed. Hamilton, Ontario: BC Decker, Inc., 2006; p. 537-48.
2. MacCormack M.A. "Photodynamic therapy". Adv Dermatol. 22:219-58 (2006).
3. Kessel D., Vicente, M.G., Reiners, J.J., Jr. "Initiation of apoptosis and autophagy by photodynamic therapy". Lasers Surg Med. 38(5):482-8 (2006).
4. Hartevelt M.M., Bavinck, J.N., Kootte, A.M., Vermeer, B.J., Vandenbroucke, J.P. "Incidence of skin cancer after renal transplantation in The Netherlands". Transplantation. 49(3):506-9 (1990).
5. Jensen P., Hansen, S., Moller, B., et al. "Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens". J Am Acad Dermatol. 40(2 Pt 1):177-86 (1999).
6. Lindelof B., Sigurgeirsson, B., Gabel, H., Stern, R.S. "Incidence of skin cancer in 5356 patients following organ transplantation". Br J Dermatol. 143(3):513-9 (2000).
7. Bavinck J.N., De Boer, A., Vermeer, B.J., et al. "Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients". Br J Dermatol. 129(3):242-9 (1993).
8. Marks R., Rennie, G., Selwood, T. "The relationship of basal cell carcinomas and squamous cell carcinomas to solar keratoses". Arch Dermatol. 124(7):1039-42 (1988).
9. Marks R., Rennie, G., Selwood, T.S. "Malignant transformation of solar keratoses to squamous cell carcinoma". Lancet. 1(8589):795-7 (1988).
10. Rowert-Huber J., Patel, M.J., Forschner, T., et al. "Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification". Br J Dermatol. 156 Suppl 3:8-12 (2007).
11. Braathen L.R., Szeimies, R.M., Basset-Seguin, N., et al. "Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005". J Am Acad Dermatol. 56(1):125-43 (2007).
12. Freeman M., Vinciullo, C., Francis, D., et al. "A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study". J Dermatolog Treat. 14(2):99-106 (2003).
13. Morton C., Horn, M., Leman, J., et al. "Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial". Arch Dermatol. 142(6):729-35 (2006).
14. Salim A., Leman, J.A., McColl, J.H., Chapman, R., Morton, C.A. "Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease". Br J Dermatol. 148(3):539-43 (2003).
15. Ortel B., Chen, N., Brissette, J., Dotto, G.P., Maytin, E., Hasan, T. "Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes". Br J Cancer. 77(11):1744-51 (1998).
16. Ortel B., Sharlin, D., O'Donnell, D., Sinha, A.K., Maytin, E.V., Hasan, T. "Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells". Br J Cancer. 87(11):1321-7 (2002).
17. Sinha A.K., Anand, S., Ortel, B.J., et al. "Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells". Br J Cancer. 95(4):485-95 (2006).
18. Maytin E.V., Anand, S., Sato, N., et al. Nuclear transcription factors: A new approach to enhancing cellular responses to ALA-mediated photodynamic therapy. In: Kessel D, ed. Optical methods for tumor treatment and detection: Mechanisms and techniques in Photodynamic Therapy XV. San Jose, California: SPIE- The International Society for Optical Engineering, Bellinham, WA, 2006; p. 1-10.
19. Anand S., Honari, G., Hasan, T., Elson, P., Maytin, E.V. "Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo". Clin Cancer Res. 15(10):3333-43 (2009).
20. Maytin E., Anand, S., Baran, C., et al. Enhancement and optimization of PpIX-based photodynamic therapy of skin cancer: Translational studies from bench to clinic. In: Kessel D, ed. Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XV: Intl Soc Optical Engineer, 2009; p. 71640K1-9.
21. Sato N., Moore, B.W., Keevey, S., Drazba, J.A., Hasan, T., Maytin, E.V. "Vitamin D enhances ALA-induced protoporphyrin IX production and photodynamic cell death in 3-D organotypic cultures of keratinocytes". J Invest Dermatol. 127(4):925-34 (2007).
22. Anand S., Honari, G., Paliwal, A., T., H., EV., M. Enhancement of tumor responsiveness to aminolevulinate-photodynamic therapy (ALA-PDT) using differentiation-promoting agents in mouse models of skin carcinoma. In: Kessel D, ed. Photodynamic Therapy: Back to the Future. Seattle, WA: Intl Soc Optical Engineer, 2009; p. 73804B1-7.
23. Warren C.B., Lohser, S., Chang, S., Bailin, P.A., Maytin, E.V. In-vivo fluorescence dosimetry of aminolevulinate-based protoporphyrin IX (PpIX) accumulation in human nonmelanoma skin cancers and precancers. In: Kessel D, ed. Photodynamic Therapy: Back to the Future. Seattle, WA: Intl Soc Optical Engineer, 2009; p. 73801M1-9.
24. Nelson D.L., Cox, M.M. Lehninger Principles of Biochemistry. 4th ed. New York: W.H. Freeman and Company, 2005.
25. Hatse S., De Clercq, E., Balzarini, J. "Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation". Biochem Pharmacol. 58(4):539-55 (1999).
26. Friedman S.J., Skehan, P. "Morphological differentiation of human choriocarcinoma cells induced by methotrexate". Cancer Res. 39(6 Pt 1):1960-7 (1979).
27. Hatse S., Naesens, L., De Clercq, E., Balzarini, J. "Potent differentiation-inducing properties of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in the rat choriocarcinoma (RCHO) tumor cell model". Biochem Pharmacol. 56(7):851-9 (1998).
28. Bodner A.J., Ting, R.C., Gallo, R.C. "Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate". J Natl Cancer Inst. 67(5):1025-30 (1981).
29. Ross S.A., Jones, C.S., De Luca, L.M. "Retinoic acid and methotrexate specifically increase PHA-E-lectin binding to a 67-kDa glycoprotein in LA-N-1 human neuroblastoma cells". Int J Cancer. 62(3):303-8 (1995).
30. Schwartz P.M., Barnett, S.K., Atillasoy, E.S., Milstone, L.M. "Methotrexate induces differentiation of human keratinocytes". Proc Natl Acad Sci U S A. 89(2):594-8 (1992).
31. Burres N.S., Cass, C.E. "Inhibition of methotrexate-induced differentiation of cultured human choriocarcinoma (BeWo) cells by thymidine". Cancer Res. 47(19):5059-64 (1987).
32. Schwartz P.M., Barnett, S.K., Milstone, L.M. "Keratinocytes differentiate in response to inhibitors of deoxyribonucleotide synthesis". J Dermatol Sci. 9(2):129-35 (1995).
33. Warren C.B., Lohser, S., Wene, L.C., Pogue, B.W., Bailin, P.L., Maytin, E.V. "Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate". J Biomed Opt. 15(5):051607 (2010).
34. Anand S., Chakrabarti, E., Kawamura, H., Taylor, C.R., Maytin, E.V. "Ultraviolet light (UVB and UVA) induces the damage-responsive transcription factor CHOP/gadd153 in murine and human epidermis: evidence for a mechanism specific to intact skin". J Invest Dermatol. 125(2):323-33 (2005).